{
    "organizations": [],
    "uuid": "ef0af714469a2a400ccd8df9f1160e3e8465be80",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-spago-nanomedical-to-be-granted-us/brief-spago-nanomedical-to-be-granted-us-patent-for-tumorad-idUSFWN1QN0G8",
    "ord_in_thread": 0,
    "title": "BRIEF-Spago Nanomedical To Be Granted US Patent For Tumorad",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "March 5 (Reuters) - Spago Nanomedical Ab (Publ):\n* SPAGO NANOMEDICAL TO BE GRANTED US PATENT FOR TUMORAD® * ‍PATENT WILL SECURE MARKET EXCLUSIVITY IN USA UNTIL AT LEAST 2035 Source text for Eikon: Further company coverage: (Gdynia Newsroom)\n ",
    "published": "2018-03-05T23:01:00.000+02:00",
    "crawled": "2018-03-06T22:20:10.021+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "march",
        "reuters",
        "spago",
        "nanomedical",
        "ab",
        "publ",
        "spago",
        "nanomedical",
        "granted",
        "u",
        "patent",
        "secure",
        "market",
        "exclusivity",
        "usa",
        "least",
        "source",
        "text",
        "eikon",
        "company",
        "coverage",
        "gdynia",
        "newsroom"
    ]
}